FLORA HERBTEA BRONCHIAL HERB TONIC TEA DIN 00256374
Status: Cancelled Post Market
Holder: FLORA MANUFACTURING AND DISTRIBUTING LTD.
Molecule: TUSSILAGO PETASITES
Health Canada record
| Active ingredient(s) | TUSSILAGO PETASITES 60 %; PRIMROSE 10 %; GNAPHALIUM POLYCEPHALUM 10 %; CALENDULA 8 %; ACACIA 5 %; ANISE 3 %; POPPY 3 %; MALLOW 1 % |
|---|---|
| Dosage form | Tea (Herbal) |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1954 |
| Current status date | 07-Sep-2000 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TUSSILAGO PETASITES
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00587117 | BRONCHITIS TEA | 3 WAY HERBS LTD. | Tea (Herbal) | TUSSILAGO PETASITES 25 %; HOREHOUND 25 %; HYSSOP 20 %; ANISE 10 %; GLYCYRRHIZA GLABRA 10 %; ALTHAEA OFFICINALIS 10 % | Cancelled Post Market |
| 02063034 | FARFARA-INJEEL FORTE LIQ (4D,12D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | TUSSILAGO PETASITES 4 D | Cancelled Post Market |
| 02063026 | FARFARA-INJEEL LIQ (10D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | TUSSILAGO PETASITES 10 D | Cancelled Post Market |
| 00445436 | LAPIDAR 16 TAB | SWISS HERBAL REMEDIES LTD. | Tablet | TUSSILAGO PETASITES 30 MG; WILD THYME 28 MG; ALTHAEA OFFICINALIS 33 MG; GLYCYRRHIZA GLABRA 28 MG; CETRARIA ISLANDICA 28 MG | Cancelled Post Market |
| 01950258 | TUSSILAGO FARFARA GRANULE(1CH-30CH) | HOMEOCAN INC. | Tablet | TUSSILAGO PETASITES 1 CH | Cancelled Post Market |
| 01950231 | TUSSILAGO PETASITES GRANULE(1CH-30CH) | HOMEOCAN INC. | Tablet | TUSSILAGO PETASITES 1 CH | Cancelled Post Market |